Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
EARLY DETECTION OF COVID-19 USING BREATH ANALYSIS- FIRST CROSS-SECTIONAL STUDY
Primary objective- to identify and evaluate a set of biomarkers that represent both the genetic expression of the virus itself (SARS-CoV-2) and the metabolic activity of the immune system's response to the virus.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| COVID-19 Positive patients | Experimental | subjects who were found COVID-19 Positive according to swab test. |
|
| Healthy subjects | Other | subjects who were found COVID-19 Negative according to swab test. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Breath biopsy sampling using the ReCIVA Breath Sampler | Diagnostic Test | Breath biopsy sampling using the ReCIVA Breath Sampler |
|
| Measure | Description | Time Frame |
|---|---|---|
| Correlation between Volatile Organic Compounds pattern and COVID-19 detection status. | Correlation between the set of Volatile Organic Compounds found in breath biopsy and COVID-19 detection presence in a swab test. | Through the study completion, up to 3 months. |
| Measure | Description | Time Frame |
|---|---|---|
| Correlation between Volatile Organic Compounds pattern and time from COVID-19 detection. | Correlation between the set of Volatile Organic Compounds found in breath biopsy and time since COVID-19 detected in a swab test. | Through the study completion, up to 3 months. |
| Correlation between the set of Volatile Organic Compounds found in breath biopsy and disease intensity. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Natalie Dror, PhD | Scentech Medical Technologies Ltd | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| IDF COVID 19 Isolation Facility | Ashkelon | Israel |
No IPD is to be shared with other researchers.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Correlation between the set of Volatile Organic Compounds found in breath biopsy and intensity of COVID-19 detected in a swab test. |
| Through the study completion, up to 3 months. |
| D014777 |
| Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |